Stockholm Stock Exchange | Mid Cap
Camurus
+15.22%
Latest
-
3 months
Pareto SecuritiesNordea MarketsJefferiesSEBDNB MarketsDNBBryan GarnierCarnegieHandelsbanken Capital MarketsJefferies InternationalHandelsbanken

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia